Amy P. Sing
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
Papers in
-
- Breast Cancer Treatment Studies 17
- Cancer Genomics and Diagnostics 3
- Oncology 13
- Colorectal Cancer Treatments and Studies 4
- CAR-T cell therapy research 3
- HER2/EGFR in Cancer Research 3
- Co-authors
- Hope S. Rugo (1 shared paper)P. Kelly Marcom (1 shared paper)Frankie A. Holmes (1 shared paper)Maura N. Dickler (1 shared paper)Louis Fehrenbacher (1 shared paper)James D. Reimann (1 shared paper)Beth Overmoyer (1 shared paper)Linnea Chap (1 shared paper)
- Journals
- Journal of Clinical Oncology (8 papers)Cancer Research (3 papers)Advances in Therapy (2 papers)Journal of Surgical Oncology (2 papers)Breast Cancer Research and Treatment (2 papers)
- Partner nations
- United StatesSouth KoreaGreece
In The Last Decade
Amy P. Sing
31 papers receiving 1.9k citations
Amy P. Sing's Hit Papers
Peers
Comparison fields: 5 of 79
- Cancer Research 625
- Oncology 1.0k
- Pathology and Forensic Medicine 166
- Pulmonary and Respiratory Medicine 278
- Immunology 146
Countries citing papers authored by Amy P. Sing
This map shows the geographic impact of Amy P. Sing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy P. Sing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy P. Sing more than expected).
Fields of papers citing papers by Amy P. Sing
This network shows the impact of papers produced by Amy P. Sing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy P. Sing. The network helps show where Amy P. Sing may publish in the future.
Co-authors
The 25 scholars most cited alongside Amy P. Sing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase III Trial of Capecitabine Compared With Bevacizumab Plus Capecitabine in Patients With Previously Treated Metastatic Breast Cancer Hit paper breakdown → | 2005 | 1006 |
| 2 | 2017 | 105 | |
| 3 | 2010 | 95 | |
| 4 | 1997 | 95 | |
| 5 | A phase I trial of the single-chain immunotoxin SGN-10 (BR96 sFv-PE40) in patients with advanced solid tumors. | 2002 | 82 |
| 6 | 2017 | 71 | |
| 7 | 2016 | 62 | |
| 8 | 2016 | 62 | |
| 9 | 2015 | 45 | |
| 10 | 2012 | 41 | |
| 11 | 2017 | 35 | |
| 12 | 2011 | 32 | |
| 13 | 2015 | 31 | |
| 14 | 2015 | 30 | |
| 15 | 2015 | 26 | |
| 16 | 2011 | 23 | |
| 17 | Genetic modification of T-cell clones for therapy of human viral and malignant diseases. | 1998 | 15 |
| 18 | 2016 | 11 | |
| 19 | 1984 | 11 | |
| 20 | 2014 | 6 |
About Amy P. Sing
Amy P. Sing is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Epidemiology and Immunology, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (17 papers), Advanced Breast Cancer Therapies (4 papers), Colorectal Cancer Treatments and Studies (4 papers), CAR-T cell therapy research (3 papers), Cytomegalovirus and herpesvirus research (3 papers), Cancer Genomics and Diagnostics (3 papers), HER2/EGFR in Cancer Research (3 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Cancer Research (625 citations), Oncology (1.0k citations), Pathology and Forensic Medicine (166 citations), Pulmonary and Respiratory Medicine (278 citations) and Immunology (146 citations). Amy P. Sing has collaborated with scholars based in United States, South Korea and Greece. Frequent co-authors include Hope S. Rugo, P. Kelly Marcom, Frankie A. Holmes, Maura N. Dickler, Louis Fehrenbacher, James D. Reimann, Beth Overmoyer, Linnea Chap, Melody Cobleigh and Virginia K. Langmuir. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Advances in Therapy, Journal of Surgical Oncology and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.